Frontiers in Endocrinology

Incretin analogues as cardiovascular agents: a state-of-the-art review

By Diego Araiza Garaygordobil, Jorge E. Rico-Fontalvo, Betsabe Hernández-Balbuena, Monica Vinay-Coro, Mauricio González-Arias

ReviewInterventions

The paper

Diego Araiza Garaygordobil, Jorge E. Rico-Fontalvo, Betsabe Hernández-Balbuena, Monica Vinay-Coro, Mauricio González-Arias

Instituto Nacional de Cardiología; Hospital Center

Frontiers in Endocrinology, 24 Jul 2026

doi.org/10.3389/fendo.2026.1898812 PubMed 42568490

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance